Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹75 Cr
Revenue (TTM)
₹62 Cr
Net Profit (TTM)
₹6 Cr
ROE
33.8 %
ROCE
26.6 %
P/E Ratio
12.5
P/B Ratio
2.8
Industry P/E
37.86
EV/EBITDA
9.3
Div. Yield
0 %
Debt to Equity
1
Book Value
₹22.3
EPS
₹5.8
Face value
10
Shares outstanding
14,172,816
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aakaar Medical Technologies
| -28.0 | -15.7 | -29.0 | -- | -- | -- | -- |
|
BSE FMCG
| -12.4 | -7.1 | -11.8 | -5.9 | 3.0 | 7.6 | 8.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aakaar Medical Technologies
|
53.1 | 75.3 | 61.6 | 6.0 | -- | 33.8 | 12.5 | 2.8 |
| 352.9 | 4,605.6 | 1,088.6 | 156.8 | 15.0 | 22.6 | 29.2 | 6.7 | |
| 416.9 | 18,202.1 | 3,817.5 | 798.5 | 21.4 | 28.6 | 22.9 | 5.6 | |
| 226.5 | 524.4 | 104.9 | 13.4 | -- | 45.4 | 39.2 | 12.7 | |
| 214.2 | 7,856.6 | 2,892.8 | 342.7 | 14.0 | 24.5 | 22.9 | 5.2 | |
| 289.5 | 438.6 | 221.4 | -75.4 | -23.1 | -- | -- | -3.3 | |
| 47.9 | 92.7 | 308.8 | 3.9 | 1.5 | 10.9 | 24.2 | 2.4 | |
| 48.1 | 117.2 | 392.0 | -4.7 | 0.9 | -2.7 | -- | 0.7 | |
| 344.0 | 769.6 | 107.5 | 16.0 | -- | 29.6 | 48.2 | 11.3 | |
| 429.4 | 13,655.5 | 3,389.4 | 207.1 | 9.5 | 4.4 | 65.9 | 2.4 |
No Review & Analysis are available.
--
Incorporated
2013
Chairman
Bindi Dilip Meswani
Managing Director
Dilip Ramesh Meswani
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Aakaar Medical Technologies Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Aakaar Medical Technologies Ltd is ₹53.10 (NSE) as of 18-Mar-2026 IST. Aakaar Medical Technologies Ltd has given a return of --% in the last 1 years.
The P/E ratio of Aakaar Medical Technologies Ltd is 12.46 times as on 18-Mar-2026, a 67 discount to its peers’ median range of 37.86 times.
The P/B ratio of Aakaar Medical Technologies Ltd is 2.79 times as on 18-Mar-2026, a 60 discount to its peers’ median range of 6.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Aakaar Medical Technologies Ltd are Rs 105.00 and Rs 46.25 as of 19-Mar-2026.
Aakaar Medical Technologies Ltd has a market capitalisation of ₹ 75 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Aakaar Medical Technologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.